S|P|O
TSC2|participates_in|PKB-mediated events
RHEB|participates_in|PKB-mediated events
TSC2|participates_in|TBC/RABGAPs
GDP|participates_in|TBC/RABGAPs
TSC2|participates_in|Inhibition of TSC complex formation by PKB
TSC1|participates_in|Inhibition of TSC complex formation by PKB
Ca 2+|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
CAMK2B|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
Ca 2+|participates_in|CaMK IV-mediated phosphorylation of CREB
CAMK4|participates_in|CaMK IV-mediated phosphorylation of CREB
CAMK2B|participates_in|Post NMDA receptor activation events
CAMK4|participates_in|Post NMDA receptor activation events
UBE3A|subClassOf|protein_coding_gene
ARC (human)|subClassOf|protein_coding_gene
MTOR|participates_in|PKB-mediated events
EIF4EBP1 (human)|participates_in|PKB-mediated events
RPS6KB1 (human)|participates_in|PKB-mediated events
RPTOR|participates_in|PKB-mediated events
rapamycin|is substance that treats|mesothelioma
MTOR|causes or contributes to condition|mesothelioma
NTRK2|causes or contributes to condition|mixed glioma
HRAS|causes or contributes to condition|mixed glioma
NTRK2|causes or contributes to condition|pilomyxoid astrocytoma
KRAS|causes or contributes to condition|pilomyxoid astrocytoma
NTRK2|causes or contributes to condition|Neuroblastoma
NRAS|causes or contributes to condition|Neuroblastoma
NTRK2|causes or contributes to condition|Glioma
PIK3CA|causes or contributes to condition|Glioma
NTRK2|participates_in|Signaling by NTRK1 (TRKA)
PIK3CB|participates_in|Signaling by NTRK1 (TRKA)
PIK3CD|participates_in|Signaling by NTRK1 (TRKA)
PIK3R3|participates_in|Signaling by NTRK1 (TRKA)
PIK3R2|participates_in|Signaling by NTRK1 (TRKA)
PIK3R1|causes or contributes to condition|Glioma
HRAS|participates_in|Signaling by FGFR3
MAPK3|participates_in|Signaling by FGFR3
HRAS|participates_in|CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
MAPK1|participates_in|CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
HRAS|causes or contributes to condition|Linear nevus sebaceous
KRAS|causes or contributes to condition|Linear nevus sebaceous
NRAS|causes or contributes to condition|Linear nevus sebaceous
KRAS|participates_in|Signaling by FGFR3
MAPK1|participates_in|Signaling by FGFR3
NRAS|participates_in|Signaling by FGFR3
AKT2|participates_in|Inhibition of TSC complex formation by PKB
AKT2|participates_in|AKT-mediated inactivation of FOXO1A
AKT1|participates_in|AKT-mediated inactivation of FOXO1A
AKT3|participates_in|AKT-mediated inactivation of FOXO1A
AKT1|participates_in|PKB-mediated events
TSC1|participates_in|PKB-mediated events
AKT1|participates_in|AKT phosphorylates targets in the cytosol
TSC2|participates_in|AKT phosphorylates targets in the cytosol
AKT3|participates_in|TP53 Regulates Metabolic Genes
TSC1|participates_in|TP53 Regulates Metabolic Genes
AKT3|participates_in|AKT phosphorylates targets in the cytosol
BDNF|causes or contributes to condition|Status epilepticus without prominent motor symptoms
NTRK2|causes or contributes to condition|Status epilepticus without prominent motor symptoms
MAPK3|causes or contributes to condition|Squamous cell carcinoma
TSC1|causes or contributes to condition|Squamous cell carcinoma
MAPK3|participates_in|PI3K/AKT activation
TSC2|participates_in|PI3K/AKT activation
MAPK3|participates_in|Negative feedback regulation of MAPK pathway
MAPK1|participates_in|Negative feedback regulation of MAPK pathway
MAPK1|participates_in|IRS-mediated signalling
TSC1|participates_in|IRS-mediated signalling
MAPK1|participates_in|PI3K/AKT activation
CACNA1C|participates_in|Phase 2 - plateau phase
Ca 2+|participates_in|Phase 2 - plateau phase
GRM1|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PIK3CA|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
GRM1|causes or contributes to condition|Schizophrenia
PIK3CB|causes or contributes to condition|Schizophrenia
GRM1|participates_in|GPCR downstream signalling
PIK3CD|participates_in|GPCR downstream signalling
PIK3R3|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PIK3R2|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
GRM1|causes or contributes to condition|Alcoholism
PIK3R1|causes or contributes to condition|Alcoholism
GRM1|participates_in|Neurexins and neuroligins
HOMER1|participates_in|Neurexins and neuroligins
SHANK3|participates_in|Neurexins and neuroligins
PIK3CA|participates_in|CD28 dependent PI3K/Akt signaling
AKT2|participates_in|CD28 dependent PI3K/Akt signaling
AKT1|participates_in|CD28 dependent PI3K/Akt signaling
PIK3CA|causes or contributes to condition|Hemimegalencephaly
AKT3|causes or contributes to condition|Hemimegalencephaly
PIK3CA|causes or contributes to condition|head and neck carcinoma
PIK3CB|causes or contributes to condition|head and neck carcinoma
PIK3CA|participates_in|Regulation of signaling by CBL
PIK3CD|participates_in|Regulation of signaling by CBL
PIK3R3|participates_in|Regulation of signaling by CBL
PIK3CA|participates_in|Tie2 Signaling
PIK3R2|participates_in|Tie2 Signaling
PIK3CA|participates_in|MET activates PI3K/AKT signaling
PIK3R1|participates_in|MET activates PI3K/AKT signaling
PIK3CB|participates_in|G beta:gamma signalling through PI3Kgamma
AKT2|participates_in|G beta:gamma signalling through PI3Kgamma
AKT1|participates_in|G beta:gamma signalling through PI3Kgamma
AKT3|participates_in|G beta:gamma signalling through PI3Kgamma
PIK3CB|participates_in|Regulation of signaling by CBL
PIK3CB|participates_in|Tie2 Signaling
PIK3R1|participates_in|Tie2 Signaling
PIK3CD|participates_in|G beta:gamma signalling through PI3Kgamma
PIK3R2|participates_in|Regulation of signaling by CBL
PIK3CD|causes or contributes to condition|activated PI3K-delta syndrome
PIK3R1|causes or contributes to condition|activated PI3K-delta syndrome
PIK3R3|participates_in|CD28 dependent PI3K/Akt signaling
AKT3|participates_in|CD28 dependent PI3K/Akt signaling
PIK3R1|participates_in|Regulation of signaling by CBL
PIK3R2|participates_in|CD28 dependent PI3K/Akt signaling
PIK3R1|participates_in|CD28 dependent PI3K/Akt signaling
HOMER1|causes or contributes to condition|Schizophrenia
PIK3CA|causes or contributes to condition|Schizophrenia
HOMER1|subClassOf|protein_coding_gene
PIK3CD|subClassOf|protein_coding_gene
PIK3R3|subClassOf|protein_coding_gene
PIK3R2|subClassOf|protein_coding_gene
PIK3R1|subClassOf|protein_coding_gene
SHANK3|participates_in|RET signaling
PIK3CA|participates_in|RET signaling
PIK3CB|participates_in|RET signaling
PIK3CD|participates_in|RET signaling
PIK3R3|participates_in|RET signaling
PIK3R2|participates_in|RET signaling
PIK3R1|participates_in|RET signaling
GRIN1|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
HRAS|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
GRIN1|participates_in|SOS-mediated signalling
KRAS|participates_in|SOS-mediated signalling
NRAS|participates_in|SOS-mediated signalling
GRIN1|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
GRIN2A|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
GRIN2B|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
GRIN2D|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
DLG4|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
GRIN1|causes or contributes to condition|Epileptic encephalopathy
SYNGAP1|causes or contributes to condition|Epileptic encephalopathy
GRIN1|subClassOf|protein_coding_gene
GRIN3B|subClassOf|protein_coding_gene
GRIN3A|subClassOf|protein_coding_gene
GRIN2C|participates_in|CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
GRIN2A|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
GRIN2A|participates_in|SOS-mediated signalling
GRIN2A|causes or contributes to condition|Focal sensory seizure
SYNGAP1|causes or contributes to condition|Focal sensory seizure
GRIN2A|subClassOf|protein_coding_gene
GRIN2B|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
GRIN2B|participates_in|SOS-mediated signalling
GRIN2B|causes or contributes to condition|neurodevelopmental disorder
SYNGAP1|causes or contributes to condition|neurodevelopmental disorder
valproic acid|interacts with|GRIN2B
valproic acid|interacts with|GRIN3B
GRIN2B|subClassOf|protein_coding_gene
GRIN2D|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
GRIN2D|participates_in|SOS-mediated signalling
SYNGAP1|participates_in|SOS-mediated signalling
valproic acid|interacts with|GRIN2D
GRIN2D|causes or contributes to condition|Schizophrenia
GRIN3A|causes or contributes to condition|Schizophrenia
DLG4|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
DLG4|participates_in|SOS-mediated signalling
DLG4|causes or contributes to condition|neurodevelopmental disorder
DLG4|subClassOf|protein_coding_gene
DLG4|causes or contributes to condition|Bipolar affective disorder
GRIN3A|causes or contributes to condition|Bipolar affective disorder
SYNGAP1|participates_in|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
HRAS|participates_in|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
KRAS|participates_in|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
NRAS|participates_in|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
SYNGAP1|subClassOf|protein_coding_gene
SYNGAP1|causes or contributes to condition|Schizophrenia
GRIN2C|participates_in|SOS-mediated signalling
valproic acid|interacts with|HRAS
KRAS|subClassOf|protein_coding_gene
valproic acid|interacts with|NRAS
valproic acid|interacts with|GRIN2C
HRAS|subClassOf|protein_coding_gene
NRAS|subClassOf|protein_coding_gene
GRIN2C|subClassOf|protein_coding_gene
GRIN2C|participates_in|Ras activation upon Ca2+ influx through NMDA receptor
RHEB|participates_in|Signal Transduction
GDP|participates_in|Signal Transduction
Ras GTPase-activating protein 1 (human)|participates_in|Signal Transduction
GTP|interacts with|Ras GTPase-activating protein 1 (human)
PRKAA1|participates_in|PKB-mediated events
PRKAA2|participates_in|PKB-mediated events
PRKAB1|participates_in|PKB-mediated events
PRKAB2|participates_in|PKB-mediated events
PRKAG1|participates_in|PKB-mediated events
PRKAG2|participates_in|PKB-mediated events
PRKAG3|participates_in|PKB-mediated events
PRKAA2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB1|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAA2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAB2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAG1|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAG2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAG3|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAG2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
NF1|participates_in|RAS signaling downstream of NF1 loss-of-function variants
HRAS|participates_in|RAS signaling downstream of NF1 loss-of-function variants
KRAS|participates_in|RAS signaling downstream of NF1 loss-of-function variants
NRAS|participates_in|RAS signaling downstream of NF1 loss-of-function variants
GSK3B|participates_in|Cellular responses to stress
TSC1|participates_in|Cellular responses to stress
GSK3B|participates_in|AKT phosphorylates targets in the cytosol
GTP|participates_in|Trafficking of myristoylated proteins to the cilium
GDP|participates_in|Trafficking of myristoylated proteins to the cilium
PTEN|participates_in|PI3K/AKT activation
AKT2|participates_in|PI3K/AKT activation
PTEN|causes or contributes to condition|secretory meningioma
AKT1|causes or contributes to condition|secretory meningioma
AKT3|participates_in|PI3K/AKT activation
